Skip to content
Top Alliance
Next generation biopharmaceuticals
Top Alliance
  • Home
  • Our Company
    • Our History
    • Our Leadership
    • Our Commitment
  • What We Do
    • Discovery
    • Research & Development
    • Manufacturing
  • Science
    • LOQTORZI™
    • Pipeline
  • Patients
    • Clinical Trials
    • Expanded Access Policy
  • Media
    • News Releases
    • Scientific Publications
    • Company Publications
  • Careers
  • Contact
  • Home
  • Our Company
    • Our History
    • Our Leadership
    • Our Commitment
  • What We Do
    • Discovery
    • Research & Development
    • Manufacturing
  • Science
    • LOQTORZI™
    • Pipeline
  • Patients
    • Clinical Trials
    • Expanded Access Policy
  • Media
    • News Releases
    • Scientific Publications
    • Company Publications
  • Careers
  • Contact

Search & archives template

You are here:
  1. Home
  2. Search & archives template
Oct72020

Combination Study with JS016 and LY-CoV555 for Patients with Mild-to-Moderate COVID-19 Symptoms Met Primary and Secondary Endpoints

NewsOctober 7, 2020

Nulla a velit quis ex ornare rhoncus. Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.…

Read more
Sep282020

JUPITER-02 Phase III Global Study of Toripalimab at the Interim Analysis Met Pre-Specified Primary Endpoint of Progression-Free Survival in Recurrent or Metastatic Nasopharyngeal Carcinoma

NewsSeptember 28, 2020

Nulla a velit quis ex ornare rhoncus. Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.…

Read more
Sep102020

Junshi Biosciences Receives FDA Breakthrough Therapy Designation for Toripalimab

NewsSeptember 10, 2020

Nulla a velit quis ex ornare rhoncus. Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.…

Read more
Aug92020

TopAlliance Appoints Patricia Keegan, M.D., as Chief Medical Officer

NewsAugust 9, 2020

Former Acting Associate Director of Medical Policy Oncology Center for Excellence (OCE) ROCKVILLE, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) –…

Read more
Jul132020

Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement

NewsJuly 13, 2020

Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.

Read more
Jul122020

Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016

NewsJuly 12, 2020

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Read more
May262020

Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies

NewsMay 26, 2020

Clinical testing expected to begin in second quarter in collaboration with Eli Lilly and Company SHANGHAI, China, May 26, 2020…

Read more
May42020

Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19

NewsMay 4, 2020

Junshi Biosciences and Lilly to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19 SHANGHAI and INDIANAPOLIS, May 04,…

Read more
Mar302020

Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab

NewsMarch 30, 2020

Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences…

Read more
Feb72020

IND for Junshi Biosciences’ FIH anti-BTLA antibody approved by FDA

NewsFebruary 7, 2020

Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Read more
Load more
  • TopAlliance Biosciences Inc
© TOPALLIANCE BIOSCIENCES - 2024. All rights reserved.

company.info@topalliancebio.com

Go to Top